Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 9, 2026

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

Meningioma mouse models.

Michel Kalamarides1, Matthieu Peyre, Marco Giovannini

  • 1Department of Neurosurgery, APHP, Hopital Beaujon, Service de Neurochirurgie, 100 bvd du general Leclerc, Clichy, France. michel.kalamarides@bjn.aphp.fr

Journal of Neuro-Oncology
|August 25, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Genetically Engineered Porcine Model of Rhabdoid Tumor Predisposition Syndrome Type 1 (RTPS-1).

Cancers·2026
Same author

Comprehensive characterization of spinal ependymomas in NF2-Schwannomatosis.

Acta neuropathologica communications·2026
Same author

Evolving Management Approaches Toward Personalized Therapy in Acute Myeloid Leukemia: A Narrative Review.

Journal of personalized medicine·2026
Same author

Increased intracranial pressure in NF2‑related schwannomatosis: an underestimated danger with serious consequences.

Journal of neuro-oncology·2026
Same author

Understanding the evolving role of early palliative care in myelodysplastic syndromes: a 2026 narrative review.

Annals of hematology·2026
Same author

The importance of better understanding symptom trajectories in the evolving treatment landscape of acute myeloid leukemia.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Serum lactate dehydrogenase is associated with the presence and extent of preoperative peritumoral edema in melanoma brain metastases.

Journal of neuro-oncology·2026
Same journal

Feasibility evaluation of tumor treating fields for brainstem gliomas.

Journal of neuro-oncology·2026
Same journal

Intraoperative technological advances and new frontiers in precision glioma surgery.

Journal of neuro-oncology·2026
Same journal

Optimizing the Stupp protocol for treatment of glioblastoma: eliminating age bias, enhancing treatment timing, use of stereotactically-guided sequential boost, and dexamethasone dosing.

Journal of neuro-oncology·2026
Same journal

Gamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors.

Journal of neuro-oncology·2026
Same journal

Real-time confocal imaging for evaluation of dose-dependent effects of gamma knife radiosurgery on U87 glioblastoma cell line.

Journal of neuro-oncology·2026
See all related articles

Meningioma mouse models are crucial for understanding tumor biology and developing new treatments. Genetically engineered models targeting the NF2 gene offer significant advancements for meningioma research and therapeutic strategies.

Area of Science:

  • Neuro-oncology
  • Translational research
  • Animal models

Background:

  • Meningiomas are typically benign but can exhibit aggressive behavior, necessitating alternative treatment research.
  • Rodent models are essential for studying meningioma pathogenesis due to rare spontaneous occurrence.
  • Previous models involved xenografts or chemical induction, with limitations in replicating human disease mechanisms.

Purpose of the Study:

  • To review current meningioma mouse models for translational therapeutics.
  • To highlight advancements in understanding meningioma molecular genetics, particularly the NF2 gene.
  • To discuss the utility of genetically engineered models in preclinical studies.

Main Methods:

  • Review of existing literature on meningioma mouse models.

More Related Videos

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

Related Experiment Videos

Last Updated: Jun 9, 2026

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

  • Description of xenograft and chemically induced models.
  • Focus on genetically engineered models with targeted Nf2 gene inactivation in arachnoidal cells.
  • Main Results:

    • Genetically engineered mouse models now effectively replicate human meningioma development by targeting the NF2 gene.
    • These advanced models allow for in-depth investigation of meningioma biology and therapeutic responses.
    • Associated imaging and preclinical studies are integral to validating these models.

    Conclusions:

    • Genetically engineered mouse models, especially those inactivating Nf2, represent a significant improvement for meningioma research.
    • These models facilitate novel avenues for investigating meningioma pathogenesis and testing translational therapeutics.
    • Continued development and utilization of these models are vital for advancing clinical treatment options.